00000nam 2200000zi 4500 9.892097 CaOODSP 20250107144055 m o d f cr cn||||||||| 201005t20202020onca obs f000 0 eng d 9780660361628 CaOODSP eng rda CaOODSP n-cn--- y1y1 H82-51/2020E-PDF Oncology medicines in Canada : trends and international comparisons, 2010-2019. Ottawa, ON : Patented Medicine Prices Review Board = Conseil d'examen du prix des médicaments brevetés, 2020. ©2020 1 online resource (32 pages) : colour illustrations text txt rdacontent computer c rdamedia online resource cr rdacarrier Issued also in French under title: Les médicaments oncologiques au Canada : tendances et comparaisons internationales, 2010-2019. "October 2020." Issued also in HTML format. Includes bibliographical references. "Oncology medicines are an increasingly important driver of Canadian pharmaceutical sales. Over the past decade, this significant segment has doubled its share of the market, now accounting for $3.9 billion in sales nationally. … This analysis provides an overview of the Canadian prescription oncology market from 2010 to 2019. The chartbook is divided into three sections: the first explores the dynamics of the international market for oncology medicines; the second takes a closer look at oncology sales, market distribution, and treatment costs in Canada; and the third examines these trends in the context of Canada's private drug plans"--Introduction, page 5. Antineoplastic agents Canada Statistics. Antineoplastic agents Statistics. Antineoplastic agents Prices Canada Statistics. Antineoplastic agents Prices Statistics. Statistics lcgft Canada. Patented Medicine Prices Review Board, issuing body. Les médicaments oncologiques au Canada : (CaOODSP)9.892098 PDF 1.50 MB https://publications.gc.ca/collections/collection_2020/cepmb-pmprb/H82-51-2020-eng.pdf HTML N/A https://www.canada.ca/en/patented-medicine-prices-review/services/npduis/analytical-studies/oncology-medicines-trends-international-comparisons.html